Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Growth Shares

    Directors at this FTSE 100 company just bought over £2m worth of shares

    | Edward Sheldon, CFA

    Shares in this FTSE 100 pharma company have plummeted in recent months. And company insiders are betting on a potential…

    Read more »

    Investing Articles

    2 top shares I’ve bought for my Stocks and Shares ISA in November

    | Ben McPoland

    This writer reveals a pair of fast-growing businesses that he's recently added to his Stocks and Shares ISA for the…

    Read more »

    Investing Articles

    What on earth is going on with the AstraZeneca share price?

    | Dr. James Fox

    The AstraZeneca share price has fallen 30% from its peak in August. Dr James Fox explains what’s going on with…

    Read more »

    Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
    Growth Shares

    The AstraZeneca share price just fell 8.4% in a day. Is it time to consider buying?

    | Edward Sheldon, CFA

    The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this…

    Read more »

    Investing Articles

    If I’d put £25,000 into the FTSE 350 at the start of 2024, here’s how much I’d have today!

    | Ben McPoland

    Many FTSE shares have rebounded this year as interest rates look set to keep heading lower and market appetite for…

    Read more »

    Investing Articles

    If I’d put £10,000 into the FTSE 100’s biggest stock at the start of 2024, here’s what I’d have now

    | Roland Head

    The FTSE 100’s biggest company has romped away from the index over the last five years, but has fallen behind…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    As AstraZeneca’s share price drops 11%, does the stock look an unmissable bargain to me?

    | Simon Watkins

    AstraZeneca’s share price has fallen 11%, leaving it looking even more of a bargain to me than before, supported by…

    Read more »

    Dividend Shares

    Here are the 2025 dividend forecasts for FTSE giants Unilever, GSK, and AstraZeneca

    | Edward Sheldon, CFA

    These FTSE shares don’t have the highest yields. But Edward Sheldon believes they could deliver attractive returns in the years…

    Read more »

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    I wish I’d known about this profitable stock market investing strategy 10 years ago

    | Mark Hartley

    Long-term data suggests this investment approach yields returns that surpass the performance of major stock market indexes.

    Read more »

    Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
    Investing Articles

    2 of my favourite FTSE 100 shares have just plunged 12% and 10%! Time to buy?

    | Harvey Jones

    Harvey Jones is in bargain-hunting mode and wondering if these two FTSE 100 shares could make exciting purchases after falling…

    Read more »

    Abstract bull climbing indicators on stock chart
    Investing Articles

    As AstraZeneca’s share price drops 13% should I buy on the dip?

    | Simon Watkins

    AstraZeneca’s share price has fallen following unfavourable results for one of its new drugs, but others look good, and earnings…

    Read more »

    Young woman holding up three fingers
    Investing Articles

    3 stunning FTSE 100 shares I plan to buy in October 

    | Mark Hartley

    Our writer identifies three stocks on the FTSE 100 he feels would add the variety of growth, income and stability…

    Read more »